At the annual meeting of Medtronic last week, they announced the details of the development of their surgical robots.
Last week, the “heavy†of the multinational medical device giant Medtronic almost shocked the pharmaceutical industry. At the annual meeting, I showed the "the most versatile pharmaceutical industry" with the goal of deploying Rolex and each salesman.
.jpg)
Of course, there are reasons for the good welfare of the local companies, which are based on good products and research and development. Recently, Medtronic announced the details of the development of their surgical robots. Medtronic said that the minimally invasive surgical robot being developed will be used in the treatment of obesity, thoracic vertebrae, colorectal, urological surgery and other fields.
Compared to previous attitudes about R&D details, Medtronic announced a photo of a surgical robot prototype and a video of a recent iterative development of robotics. From the video, you can see the curved robot arm and a surgeon. The laboratory operates surgical robots and some corresponding surgical tools.
According to reports, Medtronic's Surgical Robot R&D Center has 150 R&D personnel, which are distributed in three places. The robot arm is mainly developed in Germany, and the software development is placed in Cambridge and Massachusetts. In Connecticut.
Medtronic's medical robot research and development is not alone. He has a luxurious cooperative camp, partners including the German Aerospace Center (DLR), and other research and development cooperation agencies. In May of this year, Medtronic also cooperated with an Israeli company developing robots in Mazor robots, including equity, joint marketing and cooperative development. Medtronic is the world's exclusive distributor of Mazor robots.
In terms of research and development, Medtronic maintains an open attitude and pursues “takenismâ€. “Our cooperation with these technology partners is to hope to make the most of the technology developed by these partners. If you want the products to be quickly introduced to the market, you don’t necessarily have to develop every technology of the robot, if there is any ready-made technology. The technology can be widely used to work with others, which can reduce the cost of research and development, and it is easy to make technology upgrade iterations," said Hanson, executive vice president and group president of Medtronic's minimally invasive treatment division.
Medtronic also revealed that they are discussing the timetable for applying for robot certification to the FDA, but they will not consider the United States as the starting point for the listing of surgical robots, but instead tend to bring their surgical robots to the market in India first. The reason why India was chosen as the starting point is because India's medical device supervision conditions are more relaxed than the US FDA. In order to ensure the smooth launch of surgical robots, they are prepared to adopt a steady and steady strategy.
Some analysts said that it takes a long time and effort to FDA certification. After the FDA approval, there may be more surgical robot players on the market, so this is the first time Medtronic chose to be listed in Asia and Europe outside the US. The reason is that it is easier than the FDA India medical device review, and Medtronic's surgical robot review certification must compete with time.
This surgical robot project is the largest investment in the research and development of Medtronic's minimally invasive medical department, and they are very confident and optimistic about this project. “We can do every patient who has done minimally invasive surgery on the same day out of the hospital.†Hanson said that these surgical robots have been evaluated by thousands of users and redeveloped before finalizing the design. potential.
Fish Collagen,Fish Collagen Powder,Fish Collagen Granules,Cod Skin Collagen
Ningbo Nutrition Food Technology Co.,ltd. , https://www.collagenworkshop.com